Theranostics in Soft Tissue Sarcoma Using a Vascular Disruption Approach

Summary

To test the feasibility of theranostic targeting the PSMA receptor in STS patients by Ga-68-PSMA-11 PET/CT and Lu-177-ITG-PSMA-1 treat-ment with special emphasis on vascular disruption using a translational approach.

Timeline

Start

2023-02-08

Primary completion

2024-04-09

Completion

2024-04-30

Drugs

Indications